Anaemia of chronic disorder is the onset of anaemia associated with chronic illnesses such as cancer and other inflammatory and autoimmune diseases. It is very common in patients who have rheumatoid arthritis, lupus, or certain infections. The condition occurs when patients do not have enough healthy red blood cells to provide oxygen to the tissues in the body. For effective treatment, it is important to distinguish anaemia of chronic disorder from iron-deficiency anaemia. This can be done using advanced diagnostic tests that measure the level of ferritin and total iron-binding capacity in the patient’s cells. This can help doctors determine the best course of treatment, which will also involve treating or managing the underlying chronic disease.
Such advanced diagnostic tests, as well as facilities and technology required to treat various chronic diseases, are widely available in Southeast Asia, where countries such as Singapore, Thailand, and Malaysia have gained recognition as leading medical tourism destinations.
Together, the three countries build up Southeast Asia’s impressive medical infrastructure, which continues to attract both Asians and Westerners.
Singapore has long been Asia’s number one destination for medical travellers due to its reliable, high-quality medical care. It is known as a multifaceted medical hub where specialists from various fields can be found. It is an ideal destination for patients suffering from anaemia of chronic disorder, as the country has doctors and experts who specialise in various chronic conditions, including inflammatory, autoimmune, and blood disorders. In the event that anaemic patients require blood transfusions as part of their treatment, Singapore has one of the safest blood supplies in the world. Singapore formed the Blood Services Group HSA, which was appointed in 1992 as a Collaborating Blood Centre for Transfusion Medicine by the World Health Organisation.
When it comes to quality of medical care, Thailand and Malaysia are not far behind. Thailand continuously invests in state-of-the-art medical instruments and technology. The country is the first in Asia with a hospital accredited by the Joint Commission International (JCI). Despite the country’s highly advanced, world-class healthcare facilities, its medical procedures are still up to 75% cheaper when compared to fees charged in the US and the United Kingdom.
For its part, Malaysia is currently working to expand its medical technology to help more and more international patients. Now, Malaysian hospitals are beginning to offer stem cell treatments for autoimmune diseases and other chronic diseases through Cell Malaysia, its specialist centre for stem cell therapy, as well as other similar facilities. This makes it an ideal destination for patients seeking treatment for anaemia of chronic disorder.